Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 203168, 8 pages
http://dx.doi.org/10.1155/2013/203168
Research Article

Impact of Standardized Allergen-Removed Rhus verniciflua Stokes Extract on Advanced Adenocarcinoma of the Ampulla of Vater: A Case Series

1Department of Medical Consilence, Graduate School, Jukjeon Campus, Dankook University, 152 Jukjeon-ro, Suji-gu, Yongin-si 448-701, Republic of Korea
2Department of Clinical Oncology, Integrative Cancer Center, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea
3Department of Hematology and Oncology, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea

Received 2 February 2013; Accepted 3 April 2013

Academic Editor: Thomas Efferth

Copyright © 2013 Woncheol Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Roder, P. M. Schneider, H. J. Stein, and J. R. Siewert, “Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater,” British Journal of Surgery, vol. 82, no. 12, pp. 1693–1696, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. J. R. Howe, D. S. Klimstra, R. D. Moccia, K. C. Conlon, and M. F. Brennan, “Factors predictive of survival in ampullary carcinoma,” Annals of Surgery, vol. 228, no. 1, pp. 87–94, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Albores-Saavedra, A. M. Schwartz, K. Batich, and D. E. Henson, “Cancers of the ampulla of Vater: demographics, morphology, and survival based on 5,625 cases from the SEER program,” Journal of Surgical Oncology, vol. 100, no. 7, pp. 598–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Heinrich and P. A. Clavien, “Ampullary cancer,” Current Opinion in Gastroenterology, vol. 26, no. 3, pp. 280–285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. L. Qiao, Y. G. Zhao, M. L. Ye et al., “Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection,” World Journal of Surgery, vol. 31, no. 1, pp. 137–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Klempnauer, G. J. Ridder, and R. Pichlmayr, “Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head,” British Journal of Surgery, vol. 82, no. 12, pp. 1686–1691, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. O. Son, K. Y. Lee, J. C. Lee et al., “Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua stokes on normal versus transformed hepatic cell lines,” Toxicology Letters, vol. 155, no. 1, pp. 115–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. H. S. Jang, S. H. Kook, Y. O. Son et al., “Flavonoids purified from Rhus verniciflua stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells,” Biochimica et Biophysica Acta, vol. 1726, no. 3, pp. 309–316, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. H. Lee, K. S. Kim, W. C. Choi, and S. W. Yoon, “Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized Rhus verniciflua stokes extract: a case study,” Explore, vol. 5, no. 4, pp. 242–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. R. Kim, K. S. Kim, H. S. Jung, W. C. Choi, W. K. Eo, and S. H. Cheon, “A case of recurred hepatocellular carcinoma refractory to doxorubicin after liver transplantation showing response to herbal medicine product, Rhus verniciflua stokes extract,” Integrative Cancer Therapies, vol. 9, no. 1, pp. 100–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. H. Lee, W. C. Choi, K. S. Kim, J. W. Park, S. H. Lee, and S. W. Yoon, “Shrinkage of gastric cancer in an elderly patient who received Rhus verniciflua stokes extract,” Journal of Alternative and Complementary Medicine, vol. 16, no. 4, pp. 497–500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. K. Lee, H. S. Jung, W. K. Eo, S. Y. Lee, S. H. Kim, and B. S. Shim, “Rhus verniciflua stokes extract as a potential option for treatment of metastatic renal cell carcinoma: report of two cases,” Annals of Oncology, vol. 21, no. 6, pp. 1383–1385, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Lee, K. Kim, H. Jung et al., “Efficacy and safety of standardized allergen-removed Rhus verniciflua stokes extract in patients with advanced or metastatic pancreatic cancer: a Korean single-center experience,” Oncology, vol. 81, no. 5-6, pp. 312–318, 2011. View at Publisher · View at Google Scholar
  14. W. Choi, H. Jung, K. Kim et al., “Rhus verniciflua stokes against advanced cancer: a perspective from the Korean Integrative Cancer Center,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 874276, 7 pages, 2012. View at Publisher · View at Google Scholar
  15. J. C. Lee, K. Y. Lee, J. Kim et al., “Extract from Rhus verniciflua stokes is capable of inhibiting the growth of human lymphoma cells,” Food and Chemical Toxicology, vol. 42, no. 9, pp. 1383–1388, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. H. Kim, H. Y. Go, D. H. Jin et al., “Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus verniciflua stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines,” Cancer Letters, vol. 265, no. 2, pp. 197–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Kim, C. H. Jung, B. H. Jang et al., “Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua stokes,” American Journal of Chinese Medicine, vol. 37, no. 3, pp. 609–620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. D. Park, S. W. Lee, J. H. Chun, and S. H. Cha, “Clinical features of 31 patients with systemic contact dermatitis due to the ingestion of Rhus (lacquer),” British Journal of Dermatology, vol. 142, no. 5, pp. 937–942, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. T. H. Won, P. S. Seo, S. D. Park, D. L. Kim, and J. H. Park, “Clinical features in 147 patients with systemic contact dermatitis due to the ingestion of chicken boiled with Japanease lacquer tree,” Korean Journal of Dermatology, vol. 46, no. 6, pp. 761–768, 2008. View at Google Scholar · View at Scopus
  20. K. H. Yoo, S. J. Seo, K. Li, and C. K. Hong, “Ingestion of Rhus chicken causing systemic contact dermatitis in a Korean patient,” Clinical and Experimental Dermatology, vol. 35, no. 7, pp. 756–758, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. Overman, G. R. Varadhachary, S. Kopetz et al., “Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater,” Journal of Clinical Oncology, vol. 27, no. 16, pp. 2598–2603, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. M. K. Gibson, C. A. Holcroft, L. K. Kvols, and D. Haller, “Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma,” Oncologist, vol. 10, no. 2, pp. 132–137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. S. T. Kim, J. Lee, K. T. Lee et al., “The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater,” Medical Oncology, vol. 27, no. 4, pp. 1149–1154, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Peiper, I. Alldinger, R. Heller et al., “Biological and molecular characterization of a new human ampullary cancer cell line,” Anticancer Research, vol. 23, no. 1A, pp. 291–298, 2003. View at Google Scholar · View at Scopus
  25. P. Schirmacher and M. W. Büchler, “Ampullary adenocarcinoma—differentiation matters,” BMC Cancer, vol. 8, article no. 251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Santini, G. Tonini, F. M. Vecchio et al., “Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma,” Journal of Clinical Pathology, vol. 58, no. 2, pp. 159–165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Santini, B. Vincenzi, G. Tonini et al., “Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients,” Clinical Cancer Research, vol. 11, no. 10, pp. 3784–3789, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Perrone, D. Santini, A. Verzì et al., “COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables,” Journal of Clinical Pathology, vol. 59, no. 5, pp. 492–496, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Ren, Z. Qiao, H. Wang, L. Zhu, and L. Zhang, “Flavonoids: promising anticancer agents,” Medicinal Research Reviews, vol. 23, no. 4, pp. 519–534, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. C. H. Jung, J. H. Kim, M. H. Hong et al., “Phenolic-rich fraction from Rhus verniciflua stokes (RVS) suppress inflammatory response via NF-κB and JNK pathway in lipopolysaccharide-induced RAW 264.7 macrophages,” Journal of Ethnopharmacology, vol. 110, no. 3, pp. 490–497, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. J. S. Shin, Y. M. Park, J. H. Choi et al., “Sulfuretin isolated from heartwood of Rhus verniciflua inhibits LPS-induced inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines expression via the down-regulation of NF-κB in RAW 264.7 murine macrophage cells,” International Immunopharmacology, vol. 10, no. 8, pp. 943–950, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Murtaza, V. M. Adhami, B. B. Hafeez, M. Saleem, and H. Mukhtar, “Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-κB,” International Journal of Cancer, vol. 125, no. 10, pp. 2465–2473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Samoszuk, J. Tan, and G. Chorn, “The chalcone butein from Rhus verniciflua stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts,” BMC Complementary and Alternative Medicine, vol. 5, article 5, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. G. T. Y. Lau, H. Huang, S. M. Lin, and L. K. Leung, “Butein downregulates phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in cancerous and non-cancerous breast cells,” European Journal of Pharmacology, vol. 648, no. 1–3, pp. 24–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Moon, S. H. Lee, and J. H. Park, “Effect of allergen removed Rhus verniciflua extract on inhibition of tumor metastasis,” Journal of Korean Traditional Oncology, vol. 15, no. 1, pp. 47–61, 2010. View at Google Scholar
  36. W. C. Choi, E. O. Lee, H. J. Lee, S. W. Yoon, K. S. Ahn, and S. H. Kim, “Study on antiangiogenic and antitumor activities of processed Rhus verniciflua stokes extract,” Korean Journal of Oriental Physiology and Pathology, vol. 20, pp. 825–829, 2006. View at Google Scholar